Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated with Mayzent (siponimod): An OTIS Observational Pregnancy Surveillance StudyFirst published 21/06/2021 Last updated 18/07/2024 EU PAS number: EUPAS41495StudyOngoing